The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma

Japanese Journal of Urology

Volumn 88, Issue 4, 1997, Pages 473-478

  Akiyama, Kin Ya ^a   Tsuji, Masahito ^a   Kurokawa, Yasushi ^a   Yokota, Kin Ya ^a   Kojima, Keiji ^a   Naruo, Seiichi ^a   Kanayana, Hiro Omi ^a   Kagawa, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

prognostic factor; renal cell carcinoma; soluble interleukin 2 receptor

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; NONHODGKIN LYMPHOMA; PROGNOSIS;

EID: 0030971585     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.88.473     Document Type: Article

References (13)

1. Morgan, D.A., Ruscetti, F.W. and Gallo, R.: Selective in vitro growth of T lymphocytes. Science, 193, 1007-1008, 1976.
2. Sharon, M., Klausner, R.D., Cullen, B.R., Chizzonite, R. and Leonard, W.J.: Novel interleukin 2 receptor subunit detected by crosslinking under high affinity conditions. Science, 234, 859, 1986.
3. Rubin, L.A., Kurman, C.C., Fritz, M.E., Biddison, W E., Boutin, B., Yarchoan, R. and Nelson, D.L.: Soluble interleukin-2 receptors arareleased from activated human lymphoid cells in vitro. J. Immunol., 135, 3172-3177, 1985.
4. Greene, W.C, Depper, J.M., Nelson, DL. and Waldmann, T.A.: The human interleukin-2 receptor: Normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann. Int. Med., 105, 560-572, 1986.
5. Honda, M., Yamamoto, N., Nagao, S. and Tokunaga, T.: High levels of soluble interleukin 2 receptors released from human retrovirus-infected cells. Jpn. J. Cancer, Res., 78, 889-893, 1987.
6. Elsässer-Beile, U., Gallati, H., Weber, W., Wiid, E.D., Mönting, J.S. and von Kleist, S.: In-creased Plasma Concentrations for Type I and II Tumor Necrosis Factor Receptors and IL-2 Receptors in Cancer Parients. Tumor Biol., 15, 17-24, 1994.
7. Stasi, R., Zinzani, P.L , Galieni, P., Lauta, V.M., Damasio, E.D., Dammacco, F., Papa, G, and Tura, S.: Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma. Br. J. Haematol., 88, 770 -777, 1994.
8. Wang, Y.F., Wu. X.N., Zhou, Y.H., Chen, X.F., Shen, J. and Wang, H.J.: Clinical significance of elevated serum soluble interleukin-2 receptor in gastric cancer. Chin. Med, J. Engl., 107, 254 -256, 1994.
9. Sharano, S., Saha, K., Shingali, R.N. and Malik. G.B.: Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour. Cancer Immunol. Immunotherapy, 33, 198-202, 1991.
10. Gooding, R, Riches, P., Dadian, G., Moore, J. and Gore, M.: Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2. Br. J. Cancer. 72, 452-455, 1995.